A Registered Cohort Study on Charcot-Marie-Tooth Disease

Last updated: January 7, 2022
Sponsor: Ning Wang, MD., PhD.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Peripheral Neuropathy

Neuropathy

Treatment

N/A

Clinical Study ID

NCT04010188
MRCTA,ECFAH of FMU [2019] 192
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The aim of the study is to analyze the natural history data data from Charcot-Marie-Tooth disease and related disorders in China, to assess the clinical, genetic, epigenetic features of patients with Charcot-Marie-Tooth disease, and to optimize clinical management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with the clinical diagnosis of Charcot-Marie-Tooth disease
  • Genetic diagnosis of patients with Charcot-Marie-Tooth disease
  • Unrelated healthy controls

Exclusion

Exclusion Criteria:

  • Decline to participate.
  • Other peripheral neuropathy caused by trauma, immunity and toxicosis.

Study Design

Total Participants: 500
Study Start date:
July 01, 2019
Estimated Completion Date:
December 31, 2049

Connect with a study center

  • First Affiliated Hospital of Fujian Medical University

    Fuzhou,
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.